American Healthcare REIT, Inc. (AHR)
(Delayed Data from NYSE)
$26.17 USD
-0.43 (-1.62%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $26.18 +0.01 (0.04%) 7:58 PM ET
1-Strong Buy of 5 1
D Value C Growth F Momentum F VGM
American Healthcare REIT (AHR) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Downside to Average Price Target |
---|---|---|---|
$25.00 | $31.00 | $14.00 | -6.02% |
Price Target
Based on short-term price targets offered by eight analysts, the average price target for American Healthcare REIT comes to $25.00. The forecasts range from a low of $14.00 to a high of $31.00. The average price target represents a decline of 6.02% from the last closing price of $26.60.
Analyst Price Targets (8 )
Broker Rating
American Healthcare REIT currently has an average brokerage recommendation (ABR) of 1.56 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by eight brokerage firms. The current ABR compares to an ABR of 1.61 a month ago based on nine recommendations.
Of the eight recommendations deriving the current ABR, four are Strong Buy and three are Buy. Strong Buy and Buy respectively account for 50% and 37.5% of all recommendations. A month ago, Strong Buy made up 55.56%, while Buy represented 22.22%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 4 | 4 | 5 | 5 | 5 |
Buy | 3 | 3 | 2 | 2 | 2 |
Hold | 1 | 1 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.56 | 1.56 | 1.61 | 1.61 | 1.61 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
10/13/2024 | Colliers Securities | Barry Oxford | Hold | Moderate Buy |
9/16/2024 | KeyBanc Capital Markets | Austin Wurschmidt | Strong Buy | Strong Buy |
8/7/2024 | JMP Securities | Aaron Hecht | Strong Buy | Strong Buy |
7/1/2024 | Truist Securities | Michael Lewis | Strong Buy | Strong Buy |
3/4/2024 | Not Identified | Not Identified | Not Available | Hold |
3/4/2024 | Not Identified | Not Identified | Not Available | Moderate Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.56 |
ABR (Last week) | 1.56 |
# of Recs in ABR | 8 |
Average Target Price | $25.00 |
LT Growth Rate | 6.90% |
Industry | REIT and Equity Trust - Other |
Industry Rank by ABR | 66 of 252 |
Current Quarter EPS Est: | 0.32 |
AHR FAQs
American Healthcare REIT, Inc. (AHR) currently has an average brokerage recommendation (ABR) of 1.56 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 8 brokerage firms.
The average price target for American Healthcare REIT, Inc. (AHR) is $25.00. The current on short-term price targets is based on 3 reports.
The forecasts for American Healthcare REIT, Inc. (AHR) range from a low of $14 to a high of $31. The average price target represents a decline of $4.47 from the last closing price of $26.17.
The current DOWNSIDE for American Healthcare REIT, Inc. (AHR) is 4.47%
Based on short-term price targets offered by eight analysts, the average price target for American Healthcare REIT comes to $25.00. The forecasts range from a low of $14.00 to a high of $31.00. The average price target represents a decline of 6.02% from the last closing price of $26.60.